(Q34613914)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975754%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

review article

1 reference

title

The natural killer cell -- friend or foe in autoimmune disease? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975754%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author

Malin Flodström-Tullberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975754%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

F-D Shi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975754%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

N Sarvetnick

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975754%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

H-G Ljunggren

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975754%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975754%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Immunology

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975754%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975754%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975754%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

432-441

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975754%20AND%20SRC:MED&resulttype=core&format=json

Critical self-epitopes are key to the understanding of self-tolerance and autoimmunity

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Autoreactivity, dynamic tuning and selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Self-tolerance and the composition of T cell repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Regulatory T cells in the control of immune pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

The genetics of complex autoimmune diseases: non-MHC susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Environmental factors in the pathogenesis of type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Viruses, host responses, and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Viruses as triggers of autoimmunity: facts and fantasies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Antigenic mimicry, clonal selection and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Can virus infections trigger autoimmune disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Multiple pathways to induction of virus-induced autoimmune demyelination: lessons from Theiler's virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Virus-induced autoimmunity: epitope spreading to myelin autoepitopes in Theiler's virus infection of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Hepatitis C and D, retroviruses and autoimmune manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Sleeping with the enemy--endogenous superantigens in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Role of antigen-presenting cells in mediating tolerance and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Autoimmunity through infection or immunization?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Innate immunity and autoimmunity: from self-protection to self-destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

The instructive role of innate immunity in the acquired immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Innate immunity: impact on the adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Linkages of innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Biology of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

NK cells and NKT cells in innate defense against viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

The biology of human natural killer-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural killer cells and natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

The biology of natural killer cells in cancer, infection, and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

NK cell proliferation and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural killer cells in antiviral defense: function and regulation by innate cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Specific and nonspecific NK cell activation during virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

The NOD mouse as a model of SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

High hepatic natural killer cell activity in murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Exogenously-induced, natural killer cell-mediated neuronal killing: a novel pathogenetic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimm

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Post-thymectomy murine experimental autoimmune oophoritis is associated with reduced natural killer cell activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

From infection to autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Target cell defense prevents the development of diabetes after viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

NK cell functions restrain T cell responses during viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Processing and presentation of antigens by dendritic cells: implications for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Reciprocal activating interaction between natural killer cells and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Dendritic cells in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Dendritic cells that have interacted with antigen are targets for natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Suppression of B cell responses by natural killer cells is mediated through direct effects on T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Human B cell activation by autologous NK cells is regulated by CD40-CD40 ligand interaction: role of memory B cells and CD5+ B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Immune regulation: a critical link between NK cells and CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

The role of transforming growth factor beta in the generation of suppression: an interaction between CD8+ T and NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural killer cells and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Role of NK cells and TGF-beta in the regulation of T-cell-dependent antibody production in health and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural killer type 2 bias in remission of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural killer cells and recognition of MHC class I molecules: new perspectives and challenges in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Immune inhibitory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Face off--the interplay between activating and inhibitory immune receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

On guard--activating NK cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Ligands for natural killer cell receptors: redundancy or specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Strategies for target cell recognition by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Spontaneous diabetes mellitus in the Bio-Breeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Cell cycle control of pancreatic beta cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Genetic and functional relationships between MHC and NK receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Expression and function of NK cell receptors in CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Enhancement of class II-restricted T cell responses by costimulatory NK receptors for class I MHC proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural killer activating receptors trigger interferon gamma secretion from T cells and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Effect of interleukin 2 on killer cell inhibitory receptors in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Inefficient protection of human TAP-deficient fibroblasts from autologous NK cell-mediated lysis by cytokines inducing HLA class I expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

T-Cell-dependent antibody response to the dominant epitope of streptococcal polysaccharide, N-acetyl-glucosamine, is cross-reactive with cardiac myosin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Rubella infection and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Negative regulators of cytokine signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural Killer Cell Activity in Patients with Multiple Sclerosis: Interferon and Plasmapheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

A study of some immunological variables in twins, discordant for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Low dose streptozotocin induced diabetes in mice. Metabolic, light microscopical, histochemical, immunofluorescence microscopical, electron microscopical and morphometrical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Killer Cell Activating Receptors Function as Costimulatory Molecules on CD4+CD28null T Cells Clonally Expanded in Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Innate pathways that control acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural killer cell activity of mononuclear cells from rheumatoid patients measured by a conjugate-binding cytotoxicity assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

The tissue architecture of synovial membranes in inflammatory and non-inflammatory joint diseases. II. The localization of mononuclear cells as detected by monoclonal antibodies directed against T-lymphocyte subsets and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural killer cell number and activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural killing activity in sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural killer cell activity in multiple sclerosis and myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural cytotoxicity in rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Modulation of Natural Killer Cell Activity in the Rheumatoid Joint and Peripheral Blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural killer (NK) cells at inflammatory sites of patients with rheumatoid arthritis and IgM rheumatoid factor positive polyarticular juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Deficiency of monoclonal antibody (Leu 7) defined NK cells in newly diagnosed insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Effects of cyclosporin A upon humoral and cellular immune parameters in insulin-dependent diabetes mellitus type I: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Cytotoxic activity in children with insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Genetic influence on natural cytotoxicity and interferon production in multiple sclerosis studies in monozygotic discordant twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Insulin therapy corrects NK cells abnormality in type I diabetes mellitus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Enhanced natural but diminished antibody-mediated cytotoxicity in the lungs of MRLlpr/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural killer cells inhibit the development of autoantibody production in (C57BL/6 x DBA/2) F1 hybrid mice injected with DBA/2 spleen cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Natural killer cells determine the outcome of B cell–mediated autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Analysis of in situ NK cell responses during viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Reciprocal control of T helper cell and dendritic cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Lysis of human monocytes by lymphokine-activated killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Recognition of autologous dendritic cells by human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

The functional significance of epitope spreading and its regulation by co-stimulatory molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Helper activity by human large granular lymphocytes in in vitro immunoglobulin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Modulation of ongoing human immunoglobulin synthesis by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Human large granular lymphocytes induce immunoglobulin synthesis after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Homeostasis of the antibody response: immunoregulation by NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Human fetal thymus and bone marrow contain target cells for natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Direct NK cell-mediated lysis of syngenic dorsal root ganglia neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Association of MHC Class I chain-related A (MIC-A) gene polymorphism with Type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Polymorphism in the transmembrane region of the MICA gene and type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

MICA polymorphism is associated with type 1 diabetes in the Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Human Heart–Infiltrating T-Cell Clones From Rheumatic Heart Disease Patients Recognize Both Streptococcal and Cardiac Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X

Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01084.X